MSFT 435.0 0.7061% AAPL 230.65 -1.2924% NVDA 139.965 -0.9097% GOOGL 176.965 4.2934% GOOG 178.65 4.3882% AMZN 193.73 1.5197% META 594.31 0.1736% AVGO 177.28 -1.0935% TSLA 262.2401 1.0481% TSM 195.14 -0.914% LLY 831.501 -7.977% V 291.3 3.3418% JPM 224.685 0.8008% UNH 564.77 0.4696% NVO 113.15 1.0448% WMT 81.58 -0.1469% LVMUY 134.2 -1.4033% XOM 117.0342 -0.2096% LVMHF 670.0 -1.3008% MA 513.51 1.4281%

Ascend Wellness Holdings Inc

Healthcare US AAWH

0.8201USD
0.0001(0.01%)

Last update at 2024-10-30T17:30:00Z

Day Range

0.820.85
LowHigh

52 Week Range

0.461.69
LowHigh

Fundamentals

  • Previous Close 0.82
  • Market Cap233.46M
  • Volume14568
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA33.42M
  • Revenue TTM490.53M
  • Revenue Per Share TTM2.52
  • Gross Profit TTM 147.61M
  • Diluted EPS TTM-0.26

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -39.20600M -80.93700M -5.13900M -32.57500M -
Minority interest 0.00000M 0.00000M -1.59800M 1.05M 1.05M
Net income -80.89900M -122.65700M -25.43900M -31.89500M -
Selling general administrative 137.09M 116.67M 44.87M 25.83M -
Selling and marketing expenses - - - - -
Gross profit 134.56M 135.97M 60.91M 3.29M -
Reconciled depreciation 38.24M 23.58M 13.43M 4.29M -
Ebit -6.77000M -16.94800M 8.13M -26.12100M -7.13100M
Ebitda 29.29M 6.63M 21.29M -21.80300M -
Depreciation and amortization - - - - -
Non operating income net other 0.76M 0.26M - - -
Operating income -7.52600M -17.20400M 8.13M -26.12100M -
Other operating expenses - - - - -
Interest expense 32.44M 63.99M 12.99M 6.48M 0.00000M
Tax provision 41.69M 41.72M 18.70M 0.67M -
Interest income - - - - -
Net interest income -30.25600M -63.98900M -12.99300M -6.47700M -
Extraordinary items - - - - -
Non recurring 5.00M 36.51M - - -
Other items - - - - -
Income tax expense 41.69M 41.72M 18.70M 0.67M -
Total revenue 405.93M 332.38M 143.73M 12.03M -
Total operating expenses 142.09M 153.18M 135.60M 38.15M -
Cost of revenue 271.36M 196.41M 82.82M 8.74M -
Total other income expense net -6.76900M -36.86000M -0.27900M 0.02M -
Discontinued operations - - - - -
Net income from continuing ops -80.89900M -122.65700M -23.84100M -33.24200M -
Net income applicable to common shares -80.89900M -122.65700M -25.43900M -31.89500M -9.38700M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 872.16M 723.44M 427.75M - -
Intangible assets 221.09M 59.27M 50.46M - -
Earning assets - - - - -
Other current assets 162.72M 171.76M 27.66M 20.02M 15.79M
Total liab 708.75M 546.96M 423.96M - -
Total stockholder equity 163.41M 176.48M 3.79M - -
Deferred long term liab 33.61M 1.42M - - -
Other current liab 8.35M 7.82M 35.98M 2.38M -
Common stock 0.19M 0.17M - - -
Capital stock 0.19M 0.17M 0.00000M - -
Retained earnings -267.14800M -186.24900M -63.59200M -38.15300M -6.25800M
Other liab 48.68M 1.42M - - -
Good will 44.37M 42.97M 22.80M - -
Other assets 19.28M 19.57M 15.13M 4.31M 1.46M
Cash 74.15M 155.48M 56.55M - -
Cash and equivalents - - - - -
Total current liabilities 110.95M 117.39M 115.28M 16.05M 5.70M
Current deferred revenue - - - - -
Net debt 256.48M 103.31M 155.06M - -
Short term debt 11.33M 27.94M - - -
Short long term debt 11.33M 27.94M 59.33M - -
Short long term debt total - - - - -
Other stockholder equity - - - - -
Property plant equipment 388.67M 239.66M 205.18M 113.88M 27.93M
Total current assets 198.74M 258.01M 134.18M 57.38M 24.44M
Long term investments - - - - -
Net tangible assets -57.67800M 117.21M -69.47300M 13.43M 26.50M
Short term investments - - - - -
Net receivables 36.81M 31.68M 14.64M 9.42M -
Long term debt 319.30M 230.85M 152.28M - -
Inventory 97.53M 65.59M 29.00M 15.39M 0.11M
Accounts payable 91.27M 81.64M 7.36M 9.15M 1.70M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity 0.19M 0.17M - - -
Preferred stock total equity - - - - -
Retained earnings total equity -267.14800M -186.24900M - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 279.86M 19.57M 12.73M - -
Deferred long term asset charges - - - - -
Non current assets total 500.95M 298.93M 293.57M - -
Capital lease obligations 232.45M 199.96M 158.53M - -
Long term debt total 319.30M 230.85M - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -2.44500M -2.64900M -30.87200M -65.55100M -
Change to liabilities 11.80M 25.41M 1.94M 5.86M 2.65M
Total cashflows from investing activities -114.25400M -113.23300M -30.87200M -65.55100M -38.29200M
Net borrowings 76.22M 171.46M 85.57M 72.58M 37.01M
Total cash from financing activities 71.28M 252.35M 82.17M 111.06M 58.92M
Change to operating activities 7.92M -19.63600M -1.28100M -4.33500M -1.84350M
Net income -80.89900M -122.65700M -25.43900M -31.89500M -9.38700M
Change in cash -81.33500M 97.38M 45.29M 4.58M 12.33M
Begin period cash flow 155.48M 58.10M 12.80M 8.22M -
End period cash flow 74.15M 155.48M 58.10M 12.80M 8.22M
Total cash from operating activities -38.35600M -41.73800M -6.00400M -40.92900M -8.29800M
Issuance of capital stock 0.00000M 86.06M 0.00000M 38.48M -
Depreciation 37.11M 22.22M 8.79M 3.71M 3.71M
Other cashflows from investing activities -30.16700M -22.15600M -5.03200M -9.20000M -9.20000M
Dividends paid - - - - -
Change to inventory -43.81300M -36.50000M -11.89000M -15.78900M -0.17100M
Change to account receivables -6.47700M -1.34500M -6.00700M -0.22000M -0.22000M
Sale purchase of stock - 81.91M - - -
Other cashflows from financing activities -4.94800M -1.01200M -3.39900M -3.39900M -0.06450M
Change to netincome 35.44M 62.75M 11.39M -0.03400M 0.46M
Capital expenditures 81.64M 88.43M 26.42M 41.67M 51.67M
Change receivables -6.47700M -1.34500M - - -
Cash flows other operating 8.49M 8.38M - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes -81.33500M 97.38M - - -
Change in working capital -31.13800M -32.84300M -0.59500M -12.70600M -
Stock based compensation 18.98M 23.09M 0.68M 0.31M -
Other non cash items 21.87M 70.12M 5.32M 1.52M -
Free cash flow -164.25000M -130.16600M -32.55000M -102.29900M -

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
AAWH
Ascend Wellness Holdings Inc
0.0001 0.01% 0.82 - 10.88 0.43 1.35 1.48 8.72
ZTS
Zoetis Inc
0.81 0.45% 182.08 40.18 30.96 10.67 17.60 11.27 26.18
MKKGY
Merck KGaA ADR
-0.1 0.30% 32.87 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien
- -% 162.43 21.73 14.95 3.16 2.15 3.56 12.82
TAK
Takeda Pharmaceutical Co Ltd ADR
0.04 0.29% 13.89 32.67 11.53 0.01 0.87 0.02 0.07

Reports Covered

Stock Research & News

Profile

Ascend Wellness Holdings, Inc. engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods. It owns, operates, and manages cannabis cultivation facilities and dispensaries in several states across the United States, including Illinois, Massachusetts, Michigan, Ohio, New Jersey, and Pennsylvania. The company's cannabis product categories include flowers, pre-rolls, concentrates, vapes, edibles, and other cannabis-related products. As of December 31, 2022, it operated 24 retail locations. The company also sells its products through company-owned retail stores and third-party licensed retail cannabis stores. Ascend Wellness Holdings, Inc. was incorporated in 2018 and is headquartered in New York, New York.

Ascend Wellness Holdings Inc

1411 Broadway, New York, NY, United States, 10018

Key Executives

Name Title Year Born
Mr. Abner B. Kurtin Founder & Exec. Chairman of The Board 1967
Mr. Francis Perullo Co-Founder, Interim Co-CEO, Pres, Chief Strategy Officer, Sec. & Director 1977
Mr. Daniel Neville Interim Co-CEO, CFO, Treasurer & Director 1986
Mr. David Gacom Chief Operating Officer NA
Mr. Roman Nemchenko Sr. VP & Chief Accounting Officer NA
Ms. Rebecca Conti Koar B.Sc. Sr. VP of Investor Relations NA
Ms. Robin Debiase Chief People Officer 1971
Mr. Christopher Melillo Chief Revenue Officer 1974
Jason Liotta Sr. VP of Fin. NA
Mr. Brian Miesieski Chief Brand Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.